Researcher
Sare Verstockt
- Disciplines:Endocrinology and metabolic diseases, Gastro-enterology and hepatology, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Oct 2019 → Today - Laboratory for Complex Genetics (Division)
Member
From1 Oct 2015 → 30 Sep 2019
Projects
1 - 3 of 3
- Characterization of triggers of post-operative recurrence in Crohn’s disease in both the external and luminal side of the intestineFrom1 Jan 2023 → TodayFunding: FWO research project
- Lipidomic, microbial and functional characterization of triggers of post-operative recurrence in Crohn’s diseaseFrom1 Oct 2021 → TodayFunding: FWO junior postdoctoral fellowship
- Molecular profiling of early events in the pathogenesis of inflammatory bowel diseaseFrom1 Oct 2015 → 9 Oct 2019Funding: BOF - doctoral mandates, BOF - Doctoral projects
Publications
21 - 30 of 44
- Inflammatory Bowel Disease (IBD)-A Textbook Case for Multi-Centric Banking of Human Biological Materials(2019)
Authors: Isabelle Cleynen, Sare Verstockt, Bram Verstockt, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Nadine Ectors
- Molecular profiling of early events in the pathogenesis of inflammatory bowel disease(2019)
Authors: Sare Verstockt, Isabelle Cleynen, An Goris, Séverine Vermeire
- TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients?(2019)
Authors: Bram Verstockt, Sare Verstockt, Isabelle Cleynen, Magali de Bruyn, Gert Van Assche, Séverine Vermeire, Marc Ferrante
Pages: 1531 - + - Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease(2019)
Authors: Sare Verstockt, Gert De Hertogh, Bram Verstockt, Kathleen Machiels, Frans Schuit, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ingrid Arijs, Isabelle Cleynen
Pages: 916 - 930 - PREDICTING ENDOSCOPIC RESPONSE IN USTEKINUMAB TREATED PATIENTS WITH CROHN'S DISEASE TRHOUGH AN INTEGRATED MULTI-OMICS BIOMARKER(2019)
Authors: Bram Verstockt, Padhmanand Sudhakar, Brecht Creyns, Sare Verstockt, Gert Van Assche, Christine Breynaert, Séverine Vermeire, Marc Ferrante
Pages: S656 - S656 - TREM1, THE FIRST ANTI-TNF SPECIFIC BIOMARKER GUIDING THERAPEUTIC DECISION IN INFLAMMATORY BOWEL DISEASE(2019)
Authors: Bram Verstockt, Sare Verstockt, Jonas Dehairs, Christine Breynaert, Gert Van Assche, Séverine Vermeire, Marc Ferrante
Pages: S67 - S67 - PREDICTING VEDOLIZUMAB INDUCED ENDOSCOPIC REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE VIA A SPECIFIC FOUR-GENE COLONIC SIGNATURE(2019)
Authors: Bram Verstockt, Sare Verstockt, Padhmanand Sudhakar, Jonas Dehairs, Gert Van Assche, Séverine Vermeire, Marc Ferrante
Pages: S109 - S110 - Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease(2019)
Authors: Bram Verstockt, Sare Verstockt, Brecht Creyns, Gert Van Assche, Ann Gils, Jan Ceuppens, Séverine Vermeire, Marc Ferrante, Christine Breynaert
Pages: 572 - 581 - Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease(2019)
Authors: Bram Verstockt, Sare Verstockt, Jonas Dehairs, Christine Breynaert, Gert Van Assche, Séverine Vermeire, Marc Ferrante
Pages: 733 - 742 - Genetic Influences on the Development of Fibrosis in Inflammatory Bowel Disease(2018)
Authors: Bram Verstockt, Sare Verstockt, Isabelle Cleynen
Pages: 13 - 38